First PREMIER Bank’s Gilead Sciences GILD Stock Holding History

First PREMIER Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$719K	Hold	5,692	–	–	0.12%	107
2026 Q1	$793K	Sell	5,692 -42	-0.7%	-$5.88K	0.18%	93
2025 Q4	$704K	Sell	5,734 -213	-4%	-$25.9K	0.16%	98
2025 Q3	$660K	Hold	5,947	–	–	0.15%	98
2025 Q2	$659K	Hold	5,947	–	–	0.16%	97
2025 Q1	$666K	Sell	5,947 -1,065	-15%	-$110K	0.17%	96
2024 Q4	$648K	Hold	7,012	–	–	0.17%	88
2024 Q3	$589K	Sell	7,012 -1,380	-16%	-$105K	0.15%	97
2024 Q2	$576K	Sell	8,392 -1,113	-12%	-$74.3K	0.15%	97
2024 Q1	$696K	Sell	9,505 -130	-1%	-$10K	0.18%	97
2023 Q4	$780K	Hold	9,635	–	–	0.22%	88
2023 Q3	$722K	Sell	9,635 -1,643	-15%	-$126K	0.22%	85
2023 Q2	$868K	Sell	11,278 -500	-4%	-$39.9K	0.25%	81
2023 Q1	$978K	Sell	11,778 -100	-0.8%	-$8.28K	0.29%	75
2022 Q4	$1.02M	Sell	11,878 -5,385	-31%	-$426K	0.31%	70
2022 Q3	$1.06M	Buy	17,263 +390	+2%	+$24.6K	0.35%	65
2022 Q2	$1.04M	Sell	16,873 -13	-0.1%	-$805	0.31%	69
2022 Q1	$1M	Buy	16,886 +1,000	+6%	+$63.9K	0.26%	80
2021 Q4	$1.15M	Hold	15,886	–	–	0.3%	72
2021 Q3	$1.11M	Hold	15,886	–	–	0.31%	72
2021 Q2	$1.09M	Sell	15,886 -2,383	-13%	-$159K	0.32%	70
2021 Q1	$1.18M	Buy	18,269 +1,554	+9%	+$100K	0.42%	65
2020 Q4	$975K	Sell	16,715 -930	-5%	-$56.1K	0.39%	63
2020 Q3	$1.11M	Buy	17,645 +500	+3%	+$34.7K	0.49%	58
2020 Q2	$1.32M	Sell	17,145 -375	-2%	-$28.7K	0.64%	47
2020 Q1	$1.31M	Buy	17,520 +45	+0.3%	+$3.11K	0.73%	43
2019 Q4	$1.14M	Sell	17,475 -4,132	-19%	-$269K	0.53%	56
2019 Q3	$1.37M	Sell	21,607 -430	-2%	-$28.1K	0.71%	43
2019 Q2	$1.49M	Sell	22,037 -200	-0.9%	-$13.2K	0.81%	38
2019 Q1	$1.45M	Buy	22,237 +15	+0.1%	+$997	0.83%	37
2018 Q4	$1.39M	Sell	22,222 -2,860	-11%	-$200K	0.9%	37
2018 Q3	$1.94M	Sell	25,082 -712	-3%	-$53.8K	1.2%	29
2018 Q2	$1.83M	Buy	25,794 +155	+0.6%	+$10.9K	1.23%	27
2018 Q1	$1.93M	Sell	25,639 -287	-1%	-$22.8K	1.42%	21
2017 Q4	$1.86M	Buy	25,926 +2,682	+12%	+$204K	1.28%	24
2017 Q3	$1.88M	Buy	23,244 +1,711	+8%	+$131K	1.32%	23
2017 Q2	$1.52M	Buy	21,533 +1,787	+9%	+$119K	1.15%	31
2017 Q1	$1.34M	Buy	19,746 +8,101	+70%	+$570K	1.02%	34
2016 Q4	$834K	Buy	11,645 +2,765	+31%	+$206K	0.64%	42
2016 Q3	$703K	Buy	+8,880	New	+$721K	0.53%	47

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First PREMIER Bank's GILD Position: Q2 2026 in Review

First PREMIER Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 5,692 shares worth $719K. The position accounts for 0.12% of the portfolio, ranked #107.

First PREMIER Bank first reported a position in GILD in Q3 2016 and has held it in 40 quarters since. The position peaked at $1.94M in Q3 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

First PREMIER Bank held 5,692 shares of Gilead Sciences worth $719K as of Q2 2026.
First PREMIER Bank left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.12% of First PREMIER Bank's portfolio in Q2 2026, its #107 holding.
First PREMIER Bank first reported a position in Gilead Sciences in Q3 2016 and has held it in 40 quarters since.
First PREMIER Bank's Gilead Sciences position peaked at $1.94M in Q3 2018.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.